Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial
EGGERMONT, Alexander M. M, SUCIU, Stefan, BASTHOLT, Lars, BORGOGNONI, Lorenzo, GRAZIA BERNENGO, Maria, DAVIDSON, Neville, POLDERS, Larissa, PRAET, Michel, SPATZ, Alan, RUTKOWSKI, Piotr, MARSDEN, Jeremy, SANTINAMI, Mario, CORRIE, Philippa, AAMDAL, Steinar, ASCIERTO, Paolo A, PATEL, Poulam M, KRUIT, Wim H
Published in Journal of clinical oncology (20.10.2013)
Published in Journal of clinical oncology (20.10.2013)
Get full text
Journal Article
Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study
Leyvraz, Serge, Suciu, Stefan, Piperno-Neumann, Sophie, Baurain, Jean-Francois, Zdzienicki, Marcin, Testori, Alessandro, Marshall, Ernest, Scheulen, Max E., Jouary, Thomas, Negrier, Sylvie, Vermorken, Jan Baptist, Kaempgen, Eckhart, Durando, Xavier, Schadendorf, Dirk, Karra Gurunath, Ravichandra, Polders, Larissa, De Schaetzen, Gaetan, Vanderschaeghe, Simon, Gauthier, Marie-Pierre, Keilholz, Ulrich
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article